Market Place
Sourcing Support
All News #Library
Rare Diseases
Therachon announces Apraglutida has received orphan drug designation in EU
22 Mar 2019 //
PRNEWSWIRE
Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide
18 Jan 2019 //
PR NEWSWIRE
Rare disease startup Therachon to absorb GLyPharma and its SBS candidate
10 Oct 2018 //
FIERCE BIOTECH
Therachon Raises $60 Million Mezzanine Financing to Advance Lead Program
14 Aug 2018 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.